WallStreetZenWallStreetZen

NASDAQ: TBIO
Telesis Bio Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their TBIO stock forecasts and price targets.

Forecast return on equity

Is TBIO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36.1%

Forecast return on assets

Is TBIO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TBIO revenue forecast

What is TBIO's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$35.5M+29.05%
Avg 2 year Forecast
$46.5M+69.04%
TBIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TBIO revenue growth forecast

How is TBIO forecast to perform vs Medical Devices companies and vs the US market?
Company
27.86%
Industry
8.28%
Market
10.3%
TBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TBIO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
TBIO$0.38N/AN/A
BTCY$1.34N/AN/A
BMRA$0.77N/AN/A
BSGM$1.10N/AN/A
DHAI$1.29N/AN/A

Telesis Bio Stock Forecast FAQ

What is TBIO's revenue growth forecast for 2024-2025?

(NASDAQ: TBIO) Telesis Bio's forecast annual revenue growth rate of 27.86% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.3%.

Telesis Bio's revenue in 2024 is $27,509,000.On average, 1 Wall Street analysts forecast TBIO's revenue for 2024 to be $1,068,666,582, with the lowest TBIO revenue forecast at $1,068,666,582, and the highest TBIO revenue forecast at $1,068,666,582.

In 2025, TBIO is forecast to generate $1,399,802,706 in revenue, with the lowest revenue forecast at $1,399,802,706 and the highest revenue forecast at $1,399,802,706.

If you're new to stock investing, here's how to buy Telesis Bio stock.

What is TBIO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TBIO) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is TBIO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TBIO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.